BCR and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, it has been demonstrated that a dormant subset of pancreatic cancer cells capable to survive oncogene ablation (like CML cells subjected to environment-enforced BCR/Abl suppression) is responsible for tumor relapse, has CSC features, and relies on oxidative phosphorylation for survival (39).